The impact of age on the efficacy and safety of catheter ablation for long-standing persistent atrial fibrillation

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2693-2698

  Zhang, Xiao Dong ^a   Gu, Jun ^a   Jiang, Wei Feng ^a   Zhao, Liang ^a   Wang, Yuan Long ^a   Liu, Yu Gang ^a   Zhou, Li ^a   Gu, Jia Ning ^a   Wu, Shao Hui ^a   Xu, Kai ^a   Liu, Xu ^a  

^a SHANGHAI CHEST HOSPITAL   (China)

Author keywords

Age; Atrial fibrillation; Catheter ablation; Complication; Recurrence

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ARTERY CATHETER; ARTICLE; BLOOD CLOTTING TIME; CASE STUDY; CATHETER ABLATION; CLINICAL FEATURE; COHORT ANALYSIS; COMPRESSION THERAPY; CONTROLLED STUDY; DISEASE DURATION; FALSE ANEURYSM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART TAMPONADE; HEMATOMA; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NERVE INJURY; OBSERVATIONAL STUDY; PATIENT CARE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; TREATMENT OUTCOME; AGE; ATRIAL FIBRILLATION; COMPARATIVE STUDY; LONGITUDINAL STUDY; MIDDLE AGED; TIME;

AGE FACTORS; AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84885606266     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.025     Document Type: Article

References (30)

1. W.M. Feingerg, J.L. Blackshear, A. Laupacis, and R.G. Hart Prevalence, age distribution, and gender of patients with atrial fibrillation Arch Intern Med 155 1995 469 473
2. S.L. Kopecky, B.J. Gersh, and M.D. McGoon The natural history of lone atrial fibrillation: a population-base study over three decades N Engl J Med 317 1987 669 674
3. S.L. Kopecky, B.J. Gersh, and M.D. McGoon Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk Arch Intern Med 159 1999 1118 1122
4. W.M. Feingerg, J.L. Blackshear, A. Laupacis, R. Kronmal, and R.G. Hart Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications Arch Intern Med 155 1995 469 473
5. P.M. Kistler, P. Sanders, and S.P. Fynn Electrophysiologic and electroanatomic changes in the human atrium associated age J Am Coll Cardiol 44 2004 109 116
6. O.M. Wazni, N.F. Marrouche, and D.O. Martin Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial JAMA 293 2005 2634 2640
7. A. Verma, and A. Natale Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients Circulation 112 2005 1214 1222
8. T.C. Tuan, S.L. Chang, and H.M. Tsao The impact of age on the electroanatomical characteristics and outcome of catheter ablation in patients with atrial fibrillation J Cardiovasc Electrophysiol 21 2010 966 972
9. E. Zado, D.J. Callans, and M. Riley Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly J Cardiovasc Electrophysiol 19 2008 621 626
10. A. Corrado, D. Patel, and L. Riedlbauchova Efficacy, safety, and outcome of atrial fibrillation ablation in septuagenarians J Cardiovasc Electrophysiol 19 2008 807 811
11. M. Bhargava, N.F. Marrouche, and D.O. Martin Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter J Cardiovasc Electrophysiol 15 2004 8 13
12. H.W. Tan, X.H. Wang, and H.F. Shi Efficacy, safety and outcome of catheter ablation for atrial fibrillation in octogenarians Int J Cardiol 145 1 2010 147 148
13. P. Santangeli, L. Di Biase, and P. Mohanty Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes J Cardiovasc Electrophysiol 23 7 2012 687 693
14. T. Yamada, and G.N. Kay Catheter ablation of atrial fibrillation in the elderly Pacing Clin Electrophysiol 32 8 2009 1085 1091
15. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, and A.J. Camm Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 19 2010 2369 2429
16. X. Liu, H.F. Shi, H.W. Tan, X.H. Wang, L. Zhou, and J.N. Gu Decreased connexin 43 and increased fibrosis in atrial regions susceptible to complex fractionated atrial electrograms Cardiology 114 2009 22 29
17. K. Nademanee, J. McKenzie, and E. Kosar A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate J Am Coll Cardiol 43 2004 2044 2053
18. S. Knecht, M. Hocini, and M. Wright Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation Eur Heart J 29 2008 2359 2366
19. X. Wang, X. Liu, and H. Shi Pulmonary vein isolation combined with substrate modification for persistent atrial fibrillation treatment in cases with valvular heart diseases Heart 95 2009 1773 1783
20. L.W. Lo, Y.J. Lin, and H.M. Tsao The impact of left atrial size on long-term outcome of catheter ablation of chronic atrial fibrillation J Cardiovasc Electrophysiol 20 11 2009 1211 1216
21. I. Hof, K. Chilukuri, and A. Arbab-Zadeh Does left atrial volume and pulmonary venous anatomy predict the outcome of catheter ablation of atrial fibrillation? J Cardiovasc Electrophysiol 20 9 2009 1005 1010
22. F. D'Ascenzo, A. Corleto, and G. Biondi-Zoccai Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a metaanalysis Int J Cardiol 167 5 2013 1984 1989
23. M. Yokokawa, R. Latchamsetty, and E. Good The impact of age on the atrial substrate: insights from patients with a low scar burden undergoing catheter ablation of persistent atrial fibrillation J Interv Card Electrophysiol 34 3 2012 287 294
24. S.L. Change, C.T. Tai, and Y.J. Lin Biatrial substrate properties in patients with atrial fibrillation J Cardiovasc Electrophysiol 18 2007 1134 1139
25. D. Patel, P. Mohanty, and L. Di Biase Outcomes and complications of catheter ablation for atrial fibrillation in females Heart Rhythm 7 2 2010 167 172
26. N. Dagres, J.R. Clague, G. Breithardt, and M. Borggrefe Significant gender-related differences in radiofrequency catheter ablation therapy J Am Coll Cardiol 42 2003 1103 1107
27. J.W. McCready, T. Smedley, and P.D. Lambiase Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation Europace 13 3 2011 355 361
28. L.C. Kok, M.J. Mangrum, D.E. Haines, and J.P. Mounsey Cerebrovascular complications associated with pulmonary vein ablation J Cardiovasc Electrophysiol 13 2002 764 767
29. N. Marrouche, D. Martin, and O. Wazni Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications Circulation 107 2003 2710 2716
30. H.U. Klemm, R. Ventura, and T. Rostock Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation J Cardiovasc Electrophysiol 17 2006 146 150